ConductScience.org, home

Comparison · NCT00960869-d91cfc3f

PA32540 vs EC-Aspirin 325 mg: The Number of Participants With Heartburn Resolution at 6 Months, i.e. no Heartburn Symptoms During the Last 7 Days Prior to the Visit

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. PA32540 vs EC-Aspirin 325 mg: The Number of Participants With Heartburn Resolution at 6 Months, i.e. no Heartburn Symptoms During the Last 7 Days Prior to the Visit. Trial comparisons, record NCT00960869-d91cfc3f. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT00960869-d91cfc3f

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.7720.7170.819wilson
Risk in group 20.5850.5240.643wilson
Risk difference, group 1 minus group 20.1880.1080.264newcombe hybrid score
Risk ratio, group 1 over group 21.321.171.49log
Odds ratio, group 1 over group 22.411.653.53log
Number needed to treat, for one more participant with the outcome on PA32540 than on EC-Aspirin 325 mg5.333.789.29from the risk difference interval

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1PA32540PA32540 tablets contain 325 mg enteric coated (EC) aspirin and 40 mg immediate-release omeprazole dosed once daily (QD)200259OG000
Group 2EC-Aspirin 325 mgEC-Aspirin 325 mg enteric coated tablet (PA32540 minus omeprazole) dosed once daily (QD)152260OG001

Outcome

Type
SECONDARY
Title
The Number of Participants With Heartburn Resolution at 6 Months, i.e. no Heartburn Symptoms During the Last 7 Days Prior to the Visit
Description
Subjects were asked whether heartburn symptoms within the 7 days prior to the visit were:~* none: no symptoms~* mild: awareness of symptom, but easily tolerated~* moderate: discomforting symptom sufficient to cause interference with normal activities (including sleep)~* severe: incapacitating symptom, with inability to perform normal activities (including sleep) Heartburn was defined as a burning feeling rising from the stomach or lower part of the chest towards the neck.
Time frame
6 months
Population
Intent to Treat (ITT) Population

Source ClinicalTrials.gov

Trial

Title
Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers
NCT number
NCT00960869
Phases
PHASE3
Conditions
Gastric Ulcer
Interventions
PA32540, EC-Aspirin 325 mg
Lead sponsor
POZEN
Results first posted
2016-02-17

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT00960869-d91cfc3f